Mangoceuticals, Inc. reported financial results for the quarter ended September 30, 2024. Revenue for the quarter was $133,368, a decrease from $245,160 in the same period the previous year. Operating expenses totaled $1,840,745, slightly down from $1,944,049 in the prior year's quarter. The company experienced a net loss of $1,999,694, compared to a net loss of $1,799,460 in the same quarter of the previous year. The decrease in revenue and net loss was attributed to delays in marketing activities due to the migration to a new telehealth platform. For the nine months ended September 30, 2024, the company had a net loss of $6,758,630, with revenues of $510,626, an increase from $487,119 in the same period last year. The company's cash and cash equivalents stood at $73,912, down from $739,006 at the end...Show More

Mangoceuticals, Inc. reported financial results for the quarter ended September 30, 2024. Revenue for the quarter was $133,368, a decrease from $245,160 in the same period the previous year. Operating expenses totaled $1,840,745, slightly down from $1,944,049 in the prior year's quarter. The company experienced a net loss of $1,999,694, compared to a net loss of $1,799,460 in the same quarter of the previous year. The decrease in revenue and net loss was attributed to delays in marketing activities due to the migration to a new telehealth platform. For the nine months ended September 30, 2024, the company had a net loss of $6,758,630, with revenues of $510,626, an increase from $487,119 in the same period last year. The company's cash and cash equivalents stood at $73,912, down from $739,006 at the end of the previous year. Mangoceuticals also reported a working deficit of $1.3 million and an accumulated deficit of $17,985,966 as of September 30, 2024. The company highlighted the need for additional funding to support operations over the next 12 months and may seek additional funding through equity or debt financings. Mangoceuticals also mentioned a strategic review process to evaluate potential transactions that could result in a change of control or a significant change in operations.